Zdrowie i gospodarka · 09/06/2006

FDA Releases Guidance on Marketed Unapproved Drugs

The Food and Drug Administration (FDA) has made available a new guidance document outlining its approach to enforcing regulations on unapproved drugs sold in the US market, replacing a previous policy on new drugs without approved NDAs or ANDAs.